Related Experiment Video
Updated: Mar 10, 2026

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
36.6K
Mutant PIK3CA Induces EMT in a Cell Type Specific Manner
Divya Bhagirath1, Xiangshan Zhao1, Sameer Mirza1
1Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Plos One
|December 13, 2016
Summary
Mutant PIK3CA, Ras, and p53 oncogenes transform breast stem cells. The epithelial-to-mesenchymal transition (EMT) varies by cell type but doesn't solely dictate oncogenesis or tumor-initiating cell expansion.
Area of Science:
- Cancer Biology
- Molecular Oncology
- Stem Cell Research
Background:
- Breast cancer subtypes exhibit differential gene expression linked to patient survival outcomes.
- PIK3CA mutations are prevalent across breast cancer subtypes and linked to tumor heterogeneity and reduced survival in basal subtypes.
- Understanding PIK3CA-induced oncogenesis and heterogeneity is crucial for targeted therapies.
Purpose of the Study:
- To investigate the combined effect of mutant PIK3CA, Ras, and p53 on the oncogenic behavior of distinct breast stem/progenitor cell lines.
- To analyze the role of epithelial-to-mesenchymal transition (EMT) in PIK3CA-driven oncogenesis and tumor heterogeneity.
- To assess the impact of these oncogenes on tumor-initiating cell populations and in-vivo tumorigenesis.
Main Methods:
- Ectopic overexpression of mutant Ras, p53, and PIK3CA constructs in two distinct breast stem/progenitor cell lines (K5+/K19- and K5+/K19+).
- In-vitro analyses including anchorage-independent soft agar colony formation assay and assessment of epithelial-to-mesenchymal transition (EMT).
- In-vivo studies involving xenotransplantation in mice to evaluate tumorigenesis, EMT maintenance, and tumor-initiating cell populations (CD44+/CD24low).
Main Results:
- The oncogene combination (m-Ras/m-p53/m-PIK3CA) efficiently transformed both K5+/K19- and K5+/K19+ cell lines in-vitro.
- A complete EMT was observed in K5+/K19- cells, while K5+/K19+ cells showed a predominantly epithelial phenotype with minor EMT.
- Both transformed cell lines exhibited increased invasion, migration, and in-vivo tumorigenesis, maintaining their respective EMT/epithelial phenotypes. K5+/K19- cells showed a higher proportion of tumor-initiating CD44+/CD24low cells.
Conclusions:
- The oncogenic transformation and subsequent tumor development are influenced by the specific cell type, as evidenced by differential EMT.
- Epithelial-to-mesenchymal transition (EMT) is a cell-type-dependent phenomenon and does not solely dictate oncogenesis.
- Combined mutations in PIK3CA, Ras, and p53 can drive tumorigenesis and expand tumor-initiating cell populations in a context-dependent manner.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K
Cadherins in Tissue Organization
4.4K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
4.4K
Induced Pluripotent Stem Cells
5.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.8K
MAPK Signaling Cascades
9.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Forced Transdifferentiation
2.4K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.4K
The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K

